New regulatory paradigms for innovative drugs to treat pediatric diseases

JAMA Pediatr. 2014 Oct;168(10):879-80. doi: 10.1001/jamapediatrics.2014.904.

Authors

Thomas J Hwang¹, Florence T Bourgeois²

Affiliations

¹ Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts2The Blackstone Group, London, England.
² Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts4Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

No abstract available

MeSH terms

Child
Drug Approval / legislation & jurisprudence*
Drug Discovery / legislation & jurisprudence*
Humans
Rare Diseases / drug therapy*
Therapies, Investigational

Grants and funding

R21 HD072382/HD/NICHD NIH HHS/United States